Completed PHASE2 INTERVENTIONAL 2-arm NCT01957293

Influence of Salbutamol on Emotional and Cognitive Functions in Healthy Subjects (Salmon-Basel)

Sponsor: Clinical Trial Unit, University Hospital Basel, Switzerland

Updated 5 times since 2017 Last updated: Dec 15, 2014 Started: Oct 31, 2013 Primary completion: Jan 31, 2014 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Memory Functions and is currently completed. Clinical Trial Unit, University Hospital Basel, Switzerland leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clinical Trial Unit, University Hospital Basel, Switzerland
Prof. Dominique de Quervain, MD

Data source: University of Basel

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Basel, Switzerland